Shanghai ZJ Bio-Tech CoSHSE:688317 -3.76%69 OCF Yield % is 2.11 as of Jun. 27, 2026, which is 36% below its 10-year median of 3.31. GuruFocus rates SHSE:688317 with a GF Score™ of 69/100 and a GF Value™ of ¥9.93 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Shanghai ZJ Bio-Tech Co ranks better than 51.06% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Shanghai ZJ Bio-Tech Co's OCF Yield % or its related term are showing as below:
SHSE:688317'
s OCF Yield % Range Over the Past 10 Years
Min: -2.88 Med: 3.31 Max: 14.23
Current: 2.11
During the past 13 years, the highest OCF Yield % of Shanghai ZJ Bio-Tech Co was 14.23%. The lowest was -2.88%. And the median was 3.31%.
SHSE:688317's OCF Yield % is ranked better than 51.06% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs SHSE:688317: 2.11
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shanghai ZJ Bio-Tech Co OCF Yield % Related Terms
Shanghai ZJ Bio-Tech Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a OCF Yield % of 2.11 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. This is 36% below median its historical median of 3.31. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #417 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 48.9%.
Is Shanghai ZJ Bio-Tech Co's OCF Yield % too high?
Shanghai ZJ Bio-Tech Co's current OCF Yield % of 2.11 is 36% below median its 10-year median of 3.31. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Shanghai ZJ Bio-Tech Co's value of 2.11 is 18.2% above this industry median. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #417 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #417 out of 852 companies for OCF Yield %. This puts Shanghai ZJ Bio-Tech Co in the upper half of its industry. The industry median OCF Yield % is 1.79. Shanghai ZJ Bio-Tech Co's value of 2.11 is 18.2% above this benchmark. While the company's 10-year median is 3.31 vs. the industry median of 1.79, Shanghai ZJ Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai ZJ Bio-Tech Co's current OCF Yield % of 2.11 is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai ZJ Bio-Tech Co's current OCF Yield % is 2.11, which is 36% below median its own 10-year median of 3.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.93, compared to a current price of ¥15.09 — trading 52% above its estimated fair value. The current OCF Yield % is 2.11, which is 36% below median its 10-year median of 3.31 and 18.2% above the Medical Devices & Instruments industry median of 1.79. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current OCF Yield % is 2.11 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.09 is trading 52% above its estimated GF Value™ of ¥9.93.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
OCF Yield %: 2.11 (36% below median its 10-year median of 3.31)
GF Value™: ¥9.93 vs. price of ¥15.09 (52% above fair value)
Industry Position: 18.2% above the Medical Devices & Instruments median (#417 of 852)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
69GF Score
Get the complete analysis for SHSE:688317
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
